- Sector Wrap: Obesity drugmakers Vivus, Arena slip AP - Mon, Sep 24, 2012
Shares of Vivus Inc. continued to slump Monday on concerns that its obesity drug Qsymia won't get approved in the European Union, and analysts took diverging views on … More »Sector Wrap: Obesity drugmakers Vivus, Arena slip
Shares of Vivus Inc. continued to slump Monday on concerns that its obesity drug Qsymia won't get approved in the European Union, and analysts took diverging views on Vivus and its competitors.
- Katie Couric opens up about battling bulimia FRAZIER MOORE - AP - Mon, Sep 24, 2012
Viewers of Katie Couric's talk show were doubtless surprised on Monday when, during the discussion of eating disorders, Couric disclosed that she had had her own struggles … More »Katie Couric opens up about battling bulimia
- Hall of Famer Jerry Rice helps NFL fight obesity BARRY WILNER - AP - Mon, Sep 24, 2012
Jerry Rice still runs "The Hill." More »Hall of Famer Jerry Rice helps NFL fight obesity
Jerry Rice still runs "The Hill."
- Studies more firmly tie sugary drinks to obesity MARILYNN MARCHIONE - AP - Fri, Sep 21, 2012
New research powerfully strengthens the case against soda and other sugary drinks as culprits in the obesity epidemic. More »Studies more firmly tie sugary drinks to obesity
- Can it! Soda studies cite stronger link to obesity Sharon Begley - Reuters - Fri, Sep 21, 2012
NEW YORK (Reuters) - As Americans debate what is most to blame for the nation's obesity epidemic, researchers say they have the strongest evidence yet that sugary drinks … More »Can it! Soda studies cite stronger link to obesity
NEW YORK (Reuters) - As Americans debate what is most to blame for the nation's obesity epidemic, researchers say they have the strongest evidence yet that sugary drinks play a leading role and that eliminating them would, more than any other single step, make a huge difference. Three studies published Friday in the New …
- Vivus says obesity drug may fail EU test, shares fall Reuters - Fri, Sep 21, 2012
(Reuters) - Vivus Inc said its obesity drug, the first diet pill launched in the United States in over a decade, is unlikely to be recommended by a European regulatory … More »Vivus says obesity drug may fail EU test, shares fall
(Reuters) - Vivus Inc said its obesity drug, the first diet pill launched in the United States in over a decade, is unlikely to be recommended by a European regulatory committee, sending its shares down 14 percent. Safety issues associated with earlier obesity drugs, such as the notorious "fen-phen" diet-drug combo, led …
- Vivus: EU to recommend against its obesity drug AP - Fri, Sep 21, 2012
Vivus Inc. said Friday it believes a panel of advisers to the European Union's health agency will recommend against approving its weight loss drug Qsymia. More »Vivus: EU to recommend against its obesity drug
Vivus Inc. said Friday it believes a panel of advisers to the European Union's health agency will recommend against approving its weight loss drug Qsymia.
- Georgia obesity rates projected to rise AP - Wed, Sep 19, 2012
A new report forecasts a sharp rise in obesity in every American state over the next 20 years, though Georgia is projected to remain in the middle of the pack. More »Georgia obesity rates projected to rise
A new report forecasts a sharp rise in obesity in every American state over the next 20 years, though Georgia is projected to remain in the middle of the pack.
- Fat and getting fatter: U.S. obesity rates to soar by 2030 Sharon Begley - Reuters - Tue, Sep 18, 2012
NEW YORK (Reuters) - If Americans stick to their eating and exercise habits, future historians will look back on the early 21st century as a golden age of svelte. Using … More »Fat and getting fatter: U.S. obesity rates to soar by 2030
NEW YORK (Reuters) - If Americans stick to their eating and exercise habits, future historians will look back on the early 21st century as a golden age of svelte. Using a model of population and other trends, a new report released on Tuesday by the Trust for America's Health and the Robert Wood Johnson Foundation projects …
- Health benefits of gastric bypass persist for years Genevra Pittman - Reuters - Tue, Sep 18, 2012
NEW YORK (Reuters Health) - The short-term benefits of weight loss surgery are well known in severely obese people, but a new study finds that improvements in diabetes … More »Health benefits of gastric bypass persist for years
NEW YORK (Reuters Health) - The short-term benefits of weight loss surgery are well known in severely obese people, but a new study finds that improvements in diabetes and blood pressure may hold up for years after the procedures. At six-year patient follow-ups, three quarters of people who'd undergone gastric bypass surgery …
- Factbox: The trends behind America's obesity epidemic Reuters - Tue, Sep 18, 2012
(Reuters) - Half of U.S. adults will be obese by 2030 unless Americans change their ways by reducing calorie consumption and increasing physical activity, according to … More »Factbox: The trends behind America's obesity epidemic
(Reuters) - Half of U.S. adults will be obese by 2030 unless Americans change their ways by reducing calorie consumption and increasing physical activity, according to a new report released on Tuesday by the Trust for America's Health and the Robert Wood Johnson Foundation. Below are some trends underlying the projection: …
- Advocates: 39 states' obesity rates to pass 50 pct MIKE STOBBE - AP - Tue, Sep 18, 2012
A group campaigning against obesity predicts that by 2030 more than half the people in 39 states will be obese — not merely overweight, but obese. More »Advocates: 39 states' obesity rates to pass 50 pct
- Study suggests tie between BPA and child obesity MIKE STOBBE - AP - Tue, Sep 18, 2012
A provocative new study suggests a connection between the BPA chemical used in food packaging and childhood obesity, but the researchers say their findings don't prove … More »Study suggests tie between BPA and child obesity
A provocative new study suggests a connection between the BPA chemical used in food packaging and childhood obesity, but the researchers say their findings don't prove it's the cause.
- Hawaii has nation's 2nd-lowest adult obesity rate AP - Tue, Sep 18, 2012
Hawaii's 2011 adult obesity rate is the second-lowest in the nation, but that could change dramatically for the worse in 20 years, according to a report released Tuesday … More »Hawaii has nation's 2nd-lowest adult obesity rate
Hawaii's 2011 adult obesity rate is the second-lowest in the nation, but that could change dramatically for the worse in 20 years, according to a report released Tuesday by two public health groups.
- Report: Va obesity rate could reach 50 pct by 2030 AP - Tue, Sep 18, 2012
Adult obesity could reach nearly 50 percent in Virginia over the next 20 years, leading to an increase in disease rates and health care costs, according to a report … More »Report: Va obesity rate could reach 50 pct by 2030
Adult obesity could reach nearly 50 percent in Virginia over the next 20 years, leading to an increase in disease rates and health care costs, according to a report released Tuesday.
- Report: Michigan obesity nearly 60 percent by 2030 AP - Tue, Sep 18, 2012
A new report says nearly 60 percent of Michigan residents could be obese by 2030 and health care costs could soar if the state doesn't start shedding pounds. More »Report: Michigan obesity nearly 60 percent by 2030
A new report says nearly 60 percent of Michigan residents could be obese by 2030 and health care costs could soar if the state doesn't start shedding pounds.
- Study links BPA, obesity in kids Genevra Pittman - Reuters - Tue, Sep 18, 2012
NEW YORK (Reuters Health) - Kids and teens that had higher levels of the chemical bisphenol A in their urine were more likely to be overweight or obese, in a new nationally-representative … More »Study links BPA, obesity in kids
NEW YORK (Reuters Health) - Kids and teens that had higher levels of the chemical bisphenol A in their urine were more likely to be overweight or obese, in a new nationally-representative U.S. study. The findings can't prove BPA - which has been banned from baby bottles but is still found in aluminum cans and other types …
- Vivus shares rise after weight loss drug launch AP - Mon, Sep 17, 2012
Shares of weight loss drugmaker Vivus Inc. rose Monday after the company announced its highly anticipated pill Qsymia is now available in the U.S. More »Vivus shares rise after weight loss drug launch
Shares of weight loss drugmaker Vivus Inc. rose Monday after the company announced its highly anticipated pill Qsymia is now available in the U.S.
- Duodenal switch a "viable option" for weight loss Genevra Pittman - Reuters - Mon, Sep 17, 2012
NEW YORK (Reuters Health) - People who had weight-loss surgery using the so-called duodenal switch technique lost more of their extra body weight and had better control … More »Duodenal switch a "viable option" for weight loss
NEW YORK (Reuters Health) - People who had weight-loss surgery using the so-called duodenal switch technique lost more of their extra body weight and had better control of diabetes and high blood pressure than those who had a more traditional gastric bypass, according to a new study. But the duodenal switch also came with …
- W.Va. gets grant for healthy school nutrition AP - Mon, Sep 17, 2012
West Virginia is getting more than $300,000 in federal funding to promote healthy meals in schools. More »W.Va. gets grant for healthy school nutrition
West Virginia is getting more than $300,000 in federal funding to promote healthy meals in schools.
- Weight Watchers says director Kim Roy resigns AP - Wed, Sep 12, 2012
Weight Watchers International Inc. said Wednesday that Kim Roy is resigning from its board of directors effective Sept. 29. More »Weight Watchers says director Kim Roy resigns
Weight Watchers International Inc. said Wednesday that Kim Roy is resigning from its board of directors effective Sept. 29.
- Rising incomes, changing diets causing sleep apnea in China David K. Randall and Hui Li - Reuters - Wed, Sep 12, 2012
NEW YORK/BEIJING (Reuters) - Thirteen years ago, Li Xin thought his swelling belly was just a sign of a healthy appetite and prosperity. But today Li, now 47, is worried … More »Rising incomes, changing diets causing sleep apnea in China
NEW YORK/BEIJING (Reuters) - Thirteen years ago, Li Xin thought his swelling belly was just a sign of a healthy appetite and prosperity. But today Li, now 47, is worried that frequent business dinners with colleagues who dine on greasy ribs, fried rice, and beer, has turned into a bigger problem. Li's mother, a dentist, …
- Deutsche Bank crash diet focuses on costs, assets Reuters - Wed, Sep 12, 2012
FRANKFURT (Reuters) - Deutsche Bank AG is targeting wasteful spending on IT systems and real estate in an austerity drive to correct previous excesses, Germany's flagship … More »Deutsche Bank crash diet focuses on costs, assets
FRANKFURT (Reuters) - Deutsche Bank AG is targeting wasteful spending on IT systems and real estate in an austerity drive to correct previous excesses, Germany's flagship international bank told analysts on Wednesday. The bank, which unveiled a raft of swinging cuts on Tuesday, said it will focus on paring back hundreds …
- U.S. obesity epidemic propels fitness as career Dorene Internicola - Reuters - Mon, Sep 10, 2012
NEW YORK (Reuters) - As the American waistline continues its spread, fitness is shaping up as one of the hottest careers of this tepid economic recovery. Employment of … More »U.S. obesity epidemic propels fitness as career
NEW YORK (Reuters) - As the American waistline continues its spread, fitness is shaping up as one of the hottest careers of this tepid economic recovery. Employment of fitness trainers and instructors is expected to grow by a brisk 24 percent in the decade to 2020, according to the U.S. Bureau of Labor Statistics, as businesses, …
- Palatin says partner AstraZeneca drops obesity drug Reuters - Fri, Sep 7, 2012
(Reuters) - Palatin Technologies Inc said its research partner AstraZeneca Plc decided to end the development of an experimental obesity drug due to an allergic reaction … More »Palatin says partner AstraZeneca drops obesity drug
(Reuters) - Palatin Technologies Inc said its research partner AstraZeneca Plc decided to end the development of an experimental obesity drug due to an allergic reaction that may be linked to the compound. Palatin's shares fell as much as 5 percent to $0.61 in early trade on the NYSE Amex. In June, AstraZeneca said an allergic …
Weight Loss News Headlines
Today on Yahoo!
1 - 8 of 48
Follow Yahoo! News
Follow @ Yahoo! News on Twitter
The official account of Yahoo! News. 100% feed-free tweets by news fans for news fans! More »
twitter.com